Definitive Contract 75F40119C10118
Award Date 9/24/19
Potential Completion Date 3/15/22
Potential Value $595K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Malvern, PA 19355, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $1,024,971 contract is for data resources and surveillance reports to support post-marketing monitoring of non-medical use of pharmaceuticals and illicit drug use. The contract has a six-month performance period with a completion date of September 29, 2026. This delivery order is part of a larger $10 million FDA indefinite...
- This is a new task order awarded under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract (HHSF223201610004I) with the Department of Health and Human Services Food and Drug Administration (FDA). The task order, valued at $2,470,791.00, is for a Pharmacokinetic (PK) study of opioid drug products following oral ingestion of chewed products. The study falls under the FDA's In Vivo Study of Generic Drug Products in Human Subjects program. The contract is a Firm Fixed Price...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a definitive, firm-fixed-price contract to Life Science Intelligence Inc., a for-profit subchapter S corporation, for the provision of Market Share Reports and Database Tracking services. The contract, which does not have a set-aside designation, was awarded on September 8, 2017, with a potential value of $386,310.00 and a completion date of September 14, 2022. The place of performance is Huntington...
- This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency, to Hager Sharp, Inc. to provide an ODSP (Opioid-Induced Dependence Syndrome Prevention) training video to educate consumers on submitting adverse events. The $254,376.76 Time and Materials contract was awarded under the Multiple Award Schedule (MAS) vehicle on September 8, 2023 and has an ultimate completion date of March 10, 2025. No set-aside was used for this award. Hager Sharp, Inc., a...
- The Department of Health and Human Services Food and Drug Administration awarded a $223,356.36 firm fixed price blanket purchase agreement call contract to Fors Marsh Group LLC. The contract is placed against the contractor's GSA Schedule for Advertising & Integrated Marketing Solutions and involves interpretation of claims in scientific publications versus promotional pieces and their impact from source quality and approval status. This quick turnaround social science research services...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price delivery order for $268,832.00 to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The order is for a "Survey of Domestic and Foreign Finished Pharmaceutical Manufacturing Practice, including Supply Chain for Management Practices for Drug Components, Containers, and Closures" and is issued under the existing Economic Studies of FDA Regulations...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,877,830 firm fixed price delivery order contract to Biopharma Services USA Inc. for NASAL PHARMACOKINETIC (PK)PHARMACODYNAMIC (PD) STUDIES OF ORAL COMBINATION PRODUCTS CONTAINING OPIOID AGONISTS AND ANTAGONISTS. As a foreign owned, self-certified small disadvantaged business, Biopharma Services USA will conduct the in vivo study of generic drug products in human subjects to fulfill the FDA's major program of...
- The Food and Drug Administration awarded a $2.24 million firm fixed-price definitive contract to the Regents of the University of Michigan on September 12, 2024, to conduct research on stimulant and opioid use disorder trajectories and associated consequences in U.S. adults using a mosaic approach. The contract, which will be performed at the University of Michigan in Ann Arbor, Michigan, is scheduled for completion by September 29, 2028. This research aligns with FDA's public health mission and...
- This is a $125,000.00 firm fixed price definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Clinicahealth, Inc., a for-profit organization, on September 16, 2019. The contract is for "SOCIAL LISTENING FOR PATIENT PERSPECTIVE ON CHRONIC PAIN STUDY-OPTION B" with a completion date of September 15, 2020. The contract does not have a set-aside designation. The place of performance is Arlington, VA 22201, USA. This contract...
- The Department of Health and Human Services Food and Drug Administration awarded a $123,277.98 firm fixed price call against the Advertising & Integrated Marketing Solutions Government-Wide Acquisition Contract to Fors Marsh Group LLC. This award is to support the agency's "Healthy Claims Experimental Study," described as a "Quick Turnaround Social Science Research Services" project. Performance will take place in Arlington, Virginia through December 2022. No...